Exane Derivatives Spdr Ser Tr Spdr S&P Biotech E Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Spdr Ser Tr Spdr S&P Biotech E stock. As of the latest transaction made, Exane Derivatives holds 6,963 shares of XBI stock, worth $678,962. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,963
Previous 963
623.05%
Holding current value
$678,962
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding XBI
# of Institutions
922Shares Held
99.9MCall Options Held
24.7MPut Options Held
43.4M-
Goldman Sachs Group Inc New York, NY9.88MShares$964 Million0.17% of portfolio
-
Citigroup Inc8.82MShares$860 Million0.56% of portfolio
-
Jpmorgan Chase & CO New York, NY7.85MShares$765 Million0.07% of portfolio
-
Bank Of America Corp Charlotte, NC7.64MShares$745 Million0.07% of portfolio
-
Morgan Stanley New York, NY7.3MShares$712 Million0.06% of portfolio